News

Filter

126 to 135 of 97217 results

Russian Ministry of Health reveals new classification of drugs for domestic market

Russian Ministry of Health reveals new classification of drugs for domestic market

10-12-2014

The Russian Ministry of Health has designed a new classification of drugs for the domestic pharmaceutical…

FinancialHealthcarePharmaceuticalPharmacologyRussia

Genesis One Nucleus 2014: personalized medicine and big data

Genesis One Nucleus 2014: personalized medicine and big data

10-12-2014

In the opening sessions at the Genesis One Nucleus 2014 conference in London yesterday, the main themes…

Evidence-based medicineHealth Medical PharmaInterviewsJohnson & JohnsonPharmaceuticalResearch

Biopharma market could be worth $41 billion this year, says Kalorama report

Biopharma market could be worth $41 billion this year, says Kalorama report

10-12-2014

Biopharma and vaccine production could be worth up to $41 billion this year, according to a report by…

BiologicBiotechnologyKaloramaKalorama InformationMarkets & Marketing

Takeda partners with Monash University on gastrointestinal research

Takeda partners with Monash University on gastrointestinal research

10-12-2014

Japan’s largest drugmaker Takeda has entered into a research partnership with the Monash Institute…

AustraliaGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticals

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

10-12-2014

Ireland-headquartered drugmaker Shire has achieved positive results in a Phase III trial of guanfacine…

Guanfacine HydrochlorideIrelandNeurologicalPharmaceuticalResearchShire

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

10-12-2014

Japanese drug maker Otsuka and Danish CNS specialist Lundbeck have announced Phase III study results…

brexpiprazoleLundbeckNeurologicalOtsukaPharmaceuticalResearchUSA

US Class Action law suit challenges pricing of Gilead's hepatitis-C drug Sovaldi

US Class Action law suit challenges pricing of Gilead's hepatitis-C drug Sovaldi

10-12-2014

US law firm Chimicles & Tikellis of Haverford, PA, has filed a law suit on behalf of the Southeastern…

Anti-viralsBiotechnologyGilead SciencesLawLegalPricingSocial IssuesSovaldiUnited StatesUSA

126 to 135 of 97217 results

Back to top